Chapter 23- Advancing Institutional Mentoring Excellence (AIME): An Institutional Inclusion Initiative

The Advancing Institutional Mentoring Excellence (AIME) pilot project was created at the University of New Mexico Health Sciences Center to address concerns by faculty of color regarding feelings of isolation, lack of representation, and suboptimal retention. The purpose of AIME was to foster an institutional culture of belonging and rigorously evaluate best practices for mentoring faculty of color toward promotion and tenure. AIME used a reciprocal mentoring model, in which both mentors and mentees increased self-efficacy and skills through a structured series of exercises and encounters. Senior faculty mentors were matched with junior faculty of color mentees through an electronic mentoring platform. The curriculum featured in-person training sessions based on an adapted RESPECT model and an AIME case study, designed to improve cross-cultural communication and interpersonal skills. The signature feature of this mentoring program was an emphasis on cognitive diversity, that is, the diverse mental tools that result from different identities and cultural backgrounds, experiences, education, and training. A mixed-methods evaluation used formative measures to gather feedback from mentors and mentees about the electronic mentoring platform and curriculum. Summative measures were used for demographic profiles and preprogram, postprogram, and follow-up surveys, as well as for focus group discussions and the “most significant change” narratives. Participants reported increased job satisfaction and satisfaction with the Health Sciences Center, as well as increased institutional connectedness and knowledge of promotion and tenure processes. Further expansion and assessment of AIME is needed to confirm findings from this pilot project regarding faculty of color retention and inclusion outcomes

A Prospective Study of Medical Student Mental Health and Attitudes of Mental Illness Disclosure

BACKGROUND: Little is known about whether students would disclose a history of mental illness on a residency or state medical licensure applications if disclosure were required. This study uses preliminary data to explore the burden of perceived mental illness among medical students, whether or not medical students would be willing to disclose this information on a residency or licensure application if prompted, and reasons for disclosure hesitance. METHODS: We electronically invited all University of New Mexico School of Medicine (UNM SOM) students enrolled in the Classes of 2019-2022 to participate in a REDCap survey about the diagnosis and treatment of mental illness. Four e-mails were sent to these students over a one-month period. This process was then repeated the following year targeting all medical students in the Classes of 2020-2023 at the UNM SOM. RESULTS: The average response rate for the two years of analysis was 49.3% (391 respondents). There was no significant effect due to difference in the two cohorts (p-value= 0.51). There was a significant effect of year in school and odds of perceived worsening of mental health (p-value= \u3c 0.001). The odds ratio of worsening mental health when compared to 1st-year students for the pooled cohorts was highest in 3rd year students at 11.8 (95% CI: 6.09-22.88). 45% of polled students perceived that their mental health worsened during medical school. 62% of students would not disclose their mental condition to ERAS and 51% of respondents would not disclose this information on a licensure application to the New Mexico Board of Medical Education if prompted. CONCLUSION: Students who perceive themselves to have mental health conditions are unlikely to disclose their mental health status on residency applications or state medical board applications when asked to do so. Furthermore there appears to be an association between year in school and mental health status, although more data is required

2020-05-29/30/31 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: NM Highlights: NM case count. Navajo Nation case update. Largest COVID-19 surge in Taos. ABQ BioPark to reopen. NM public schools reopening plan. NM unemployment claims. Rise in domestic and sexual abuse. US Highlights: Protests inspire fear of surge. Trump withdraws from WHO. Last aid bill. No new NY patients. ICE detainees sick. International Highlights: South Korea schools close. Undercounting in Russia. South African overburdened health care system. Economics, Workforce, Supply Chain, PPE: Reusable protection system. Protective household products. Longterm economic challenges. Epidemiology Highlights: Estimate virus reproduction numbers. Hypertension & cardiovascular disease impact on mortality. Gastrointestinal manifestations. Healthcare Policy Recommendations: Immunity passports are bad idea. Evaluation of hand WHO-recommended products. Opioid use-related challenges of COVID-19 management. Practice Guidelines: NICE guidelines on COVID-19 and acute kidney injury. Example of rapid conversion of an outpatient psychiatric hospital to a virtual telepsychiatry clinic. JAMA recommendations on conducting and reporting COVID-19 clinical research. Testing: Comparison of 4 antigen tests. Validation of antibody assays. Drugs, Vaccines, Therapies, Clinical Trials: Encouraging results of Ruxolitinib phase II RCT. Benefits of adjunctive herbal medicine. Potential inhibitors of viral protease screened. Anticoagulation alone is unlikely to protect from COVID-19 related morbidity and mortality. Open access database Covid19db for COVID-19 drugs. 49 new trials registered. Other Science: COVID-19 collateral damage. Telomere length and COVID-19 outcomes. Wastewater RNA early warning. Neurologic manifestation review. MRI reveals predominant anosmia cases. Self-quarantine weight gain. Immunosuppression vs. cytokine storm. Combatting misinformation

2020-04-06 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: NM case updates. Several NM policy and legislative actions. Federal vs. state conflict over medical supply lines. Healthcare workers sleep in cars to prevent family exposure. Same-day in-house testing at Cedars-Sinai. Debate over hydroxychloroquine Tx. Death rate differences: Germany and Italy. African innovations. Testing recommended with mild symptoms. CDC guidelines for law enforcement PPE. New WHO first responder training and CDC sign language resources. COVID-19 droplets can travel up to 27 feet. Transmission from the asymptomatic. Humidifiers help. Drug and vaccine progress

2020-06-03/04 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: NM Highlights: Navajo Nation to end weekend curfew. NM case count. Navajo Nation case updates. Food distribution by PepsiCo. APS to get funding. US Highlights: 5 vaccine candidates. Arizona’s increased cases. Some states postpone primaries. Pork plant infections. Economics, Workforce, Supply Chain, PPE: Impact on global supply chains. Residency selection process disrupted. Facemask filtration efficiency. Resources for underserved countries. Epidemiology Highlights: Morbidity and mortality in Africa. Healthcare Policy Recommendations: Need for social distancing. Psychological support guide. Return to work guidelines. Practice Guidelines: Anesthesia recommendations for ECT. Extracorporeal membrane oxygenation outcomes. Testing: Roche Elecsys IL-6 test is authorized by FDA to identify severe inflammatory response. Drugs, Vaccines, Therapies, Clinical Trials: HCQ RCT does not show disease prevention. Lancet HCQ study retraction. Adjunctive convalescent plasma did not show clinical improvement. Mixed remdesivir results. Virtual drug screening. Heparin improved survival. Moderna phase 3. Skin science for vaccine development. ECMO therapy. 48 new clinical trials. Other Science: Androgens and poor male outcomes. Trust in science enhances prevention compliance. High VTE prevalence in critically ill

2020-06-22/23 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: NM Highlights: Balloon Fiesta postponed. Robot to sanitize ABQ International Sunport. NMSU plan for fall 2020. NM public schools reopening plan. Fewer hospitalizations for COVID-19. NM case update. US Highlights: Visa restrictions. International Highlights: Second wave in South Korea. Epidemiology: Lockdown can suppress COVID-19. Case fatality rate associated with incidence. Predictors of ICU care and ventilators. Anxiety and depression from COVID-19. Asymptomatic patients as source of infection. Heterogeneous populations affect herd immunity. Healthcare Policy Recommendations: New FDA guidance on clinical trials conduct. Practice Guidelines: The guidelines are provided on COVID-19 diagnostics (Infectious Diseases Society of America), respiratory support for COVID-19 patients and optimizing mental care delivery during COVID-19 pandemic. Drugs, Vaccines, Therapies, Clinical Trials: Antithrombotic therapy systematic review. Drug repurposing. 58 new trials. Other Science: Safety of antihypertensives (ACEs and ARBs). Low testosterone linked to escalation of care. Neurological findings and hypercoagulability

2020-04-17/18 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: Daily NM Recap. Stimulus checks. Whitehouse reopening guidelines. Increased suicide calls. Commentary on COVID and African Americans. NYC ventilation rate. 300K African deaths predicted. Thai horse virus outbreak. Europe eases lockdown. UK vaccine research. Chinese death undercount. Biosafety breaches. General wearing of masks. PPE for emergency physician. FDA approves safer swabs. Mental health lockdown impact. Intermittent social distancing. Undetected US cases. NYC hospitalization characteristics. Adapting veterinary surveillance. Infectious disease” hospital. NIH vaccine and treatment partnership. Repurposing anesthetic machines as ventilators. Guidance for psychiatrists. Elective surgery risk stratification. Hemodialysis facility. Pathologist on IgG/M tests. Abnormal coagulation and ECMO. Paramedic guidance. Dialysis and transplants. Critically ill management. GI guidance. Otorhinolaryngology head & neck surgery. Emergency nursing management. Lung surgery. Metabolic & bariatric surgery. Convalescent plasma therapy effectiveness. Potential antivirals. UK testing. Spike proteins for potential vaccine. Cytokines suggest IL-6 antagonist treatments. Mental health messaging. $483 million for mRNA-1273 vaccine trial. WHO unsure about antibody protection. Complications for IBD. Hospitalizations characterized. Social distancing and personality. Digital COVID-19 literature database available

2020-04-16 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING

Executive Summary: Daily NM recap. Public Catholic masses resume. Chaplains stand down. Food delivered to tribal communities. Governors order face coverings use. Campfires restricted. NY hospitalizations fall. Nursing home probe in NJ. GOP call WHO Chief resignation. Africa cases up 51% and deaths up 60%. Sub-Saharan Africa prediction. Resurgence in Japan. UK conditions to reopen. France deaths up. UNMH protests over PPE. Med center financial stress. Hospitals bailout insufficient. 55% US healthcare worker cases hospital spread. Cruise ship transmission. Essential contact tracing. JAMA editors discuss policy. Guideline updates: treatment, emergency dep, ophthalmology, cath lab, telemedicine, liver disease, caregiver, health care facilities, FEMA, homeless services. Calcium channel blocker reduces fatality. Interferon lambda treatment. No benefit for lopinavir/ritonavir or arbidol in RCT. Donate plasma. Mixed results for antivirals on clearance. 37 new trials. Population-scale testing proposed. New rapid assay. Serology + RT-PCR needed. Hemoglobin monitoring. Co-infection of SARS-CoV-2. Urine glucose and proteinuria predict severity. Use damp cloth covers